SXTC icon

China SXT Pharmaceuticals

13 hedge funds and large institutions have $436K invested in China SXT Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
13
Holders Change
+5
Holders Change %
+62.5%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
4
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$126K 451,500 +430,100 +2,010%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$94K 336,469 +82,186 +32%
Citadel Advisors
3
Citadel Advisors
Florida
$75K 266,279 +266,279 New
TSS
4
Two Sigma Securities
New York
$39K 137,756 +137,756 New
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$31K 112,774 +112,774 New
VF
6
Virtu Financial
New York
$25K 90,418 +47,425 +110%
UBS Group
7
UBS Group
Switzerland
$15K 51,812 +33,199 +178%
Citigroup
8
Citigroup
New York
$10K 34,200 +34,200 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$7K 26,642
CAN
10
Cetera Advisor Networks
California
$6K 20,202 +20,202 New
Squarepoint
11
Squarepoint
New York
$5K 16,467 -1,648 -9%
Millennium Management
12
Millennium Management
New York
$3K 12,387 +12,387 New
Two Sigma Advisers
13
Two Sigma Advisers
New York
-20,400 Closed
Bank of America
14
Bank of America
North Carolina
-4,079 Closed
CFGS
15
Concourse Financial Group Securities
Alabama
HI
16
Hudock Inc
Pennsylvania
$0 3,000 +3,000 New